Chicago, 2^nd june 2025 — Clearview Market Insights (CVMI) forecasts that the global ablation technology market will grow from USD 7.5 billion in 2024 to USD 15.4 billion by 2031, reflecting a robust compound annual growth rate (CAGR) of 10.8 percent. Demand is driven by surging atrial fibrillation (AF) caseloads, rapid adoption of minimally invasive oncology treatments, and breakthrough energy modalities such as pulsed field ablation (PFA) and high intensity focused ultrasound (HIFU).

“Energy‑based ablation is reshaping how clinicians treat arrhythmias, tumors, chronic pain, and more,” said Dr Alexandra Hart, Interventional Devices Lead Analyst at CVMI. “With AI‑guided mapping, robotics, and non‑thermal tissue‑selective pulsed fields, safety profiles are improving while procedure times drop—opening the door to broader outpatient adoption.”

Request Sample @ https://clearviewmarketinsights.com/report-details/global-ablation-technology-market/

Key Figures

Growth Catalysts

• Aging & AF Epidemic — Estimated 12 million AF patients in the U.S. by 2030; catheter ablation adoption rises.
• Next‑Gen Energy — PFA catheters show single‑shot pulmonary‑vein isolation in <15 minutes with low esophageal risk.
• Oncology Shift — Liver, kidney, lung, and bone tumors increasingly treated percutaneously with microwave and cryo technologies.
• Robotics & AI — Contact‑force sensors and AI mapping reduce fluoroscopy time and improve lesion durability.
• Outpatient Migration — Ambulatory surgery centers capture rising share of pain and thyroid ablation procedures.

Leading Players

Regional Snapshot

• North America — Largest revenue share (43 %); CMS adds outpatient AF ablation codes.
• Europe — Early PFA adoption in Germany, UK; robust HIFU therapy for uterine fibroids.
• Asia‑Pacific — Fastest growth; China expands microwave liver‑tumor programs, Japan subsidies cardiac PFA.
• Latin America — RF and cryo dominate; Brazil funds public‑sector pain‑ablation centers.
• Middle East & Africa — Gulf cardiac institutes pilot robotic RF labs; oncology HIFU adoption begins.

2024‑25 Milestones

Quarter	Event	Effect
Q4 2023	Medtronic PulseSelect™ PFA CE Mark	First non‑thermal AF system approved in EU
Q2 2024	Boston Scientific completes FARAPULSE IDE	Sets stage for 2025 FDA submission
Q3 2024	AngioDynamics starts NanoKnife™ prostate IDE	Opens new urologic applicatio Ablation_Technology_Market 0 React Commentar Add Patrocinados V Buscar Buscar Patrocinados V Patrocinados V Patrocinados V Suggestions Other Understanding NDIS Melbourne and NDIS Support Melbourne: A Complete Guide   The National Disability Insurance Scheme (NDIS) is a life-changing program that helps... By adamsmith1 0 401 Financial Services What is the significance of CAGR in Mutual Funds? Introduction:   Mutual fund investment is a popular choice for individuals seeking to grow... By sundeepdutta 0 4K Food Flavored Spirits Market: Growth Factors, Trends, and Emerging Opportunities in the Alcoholic Beverage Industry The Flavored Spirits Market is experiencing significant growth as consumer preferences shift... By mrunalijadhav 0 797 Game Dominate Diablo 4 Season 8: Level Up Like a Demon with MMoexp Season 8, "Season of the Infernal Hordes," has arrived in Diablo 4 gold, bringing with it a... By Seraphinang 0 264 Other Disposable Contact Lenses Market Strategic Moves to Propel Industry Growth and Innovation in 2024 and Beyond The global disposable contact lenses market is experiencing remarkable growth, driven by various... By ayushKolhe 0 1K Patrocinados V Patrocinados V Patrocinados V © 2025 TaggedFace Español English Arabic Français Español Português Deutsch Türkçe Dutch Italiano Russian Romaian Portuguese (Brazil) Greek About Privacidad Términos Contact Us